We guide our customers into making smarter formulation choices. Ultimately, this reduces the risk of clinical failure and ensures your product reaches the clinic rapidly via the most efficient route.
Most small molecule drugs are formulated as oral solid dosage (OSD) forms, such as tablets or capsules. OSD has been an important part of the global pharmaceutical market. The formulation team of Crys...
Recent statistics indicate that approximately 70% of small molecules under development belong to Biopharmaceutics Classification System (BCS) II or IV poorly water-soluble drugs. At Crystal Pharmatech...
The development of acceptable, palatable pediatric formulations is undergoing transformation within the industry today, driven by patient needs and regulatory requirements. Therefore, the demand for a...
We will provide our valued customers with analytical chemistry research and quality control services for NCEs throughout their life cycle from the early clinical stage to commercial manufacturing. Ana...
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
By providing your e-mail address, you agree to receive an e-mail response from Crystal Pharmatech to your inquiry. The information you submit will be governed by our Privacy Policy.
